They postulated that two types of activated FoxP3+CD4+ cells exist in CRC: suppression-competent Fraction II effector Tregs (Fr-II eTregs) and non-suppressive, pro-inflammatory Fr-III non-Treg FoxP3+ T cells (33). The gene discussed is CD4; the disease is colorectal carcinoma.